Showing results (1121-1130 of 3,081) with videos related to
Sort By:
Pageof 309
Drug Safety|September 21, 2002
Hydroxyethylstarch as a risk factor for acute renal failure: is a change of clinical practice indicated?Joachim BoldtDrug Safety|January 5, 2002
Zanamivir: a review of clinical safety in individuals at high risk of developing influenza-related complicationsS Gravenstein, S L Johnston, E Loeschel, et al.Drug Safety|October 26, 2001
Prevention and management of antineoplastic-induced hypersensitivity reactionsK M Zanotti, M MarkmanDrug Safety|October 26, 2001
Postdischarge adverse drug reactions in primary care originating from hospital care in France: a nationwide prospective studyL Letrilliart, T Hanslik, M Biour, et al.Drug Safety|December 12, 2001
Risk-benefit assessment of glatiramer acetate in multiple sclerosisT Ziemssen, O Neuhaus, R HohlfeldDrug Safety|December 12, 2001
A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profilesD N Waterhouse, P G Tardi, L D Mayer, et al.Drug Safety|December 12, 2001
Measles vaccination and inflammatory bowel disease: controversy laid to rest?R L Davis, K BohlkeDrug Safety|December 12, 2001
Asthma medications and their potential adverse effects in the elderly: recommendations for prescribingD M NewnhamDrug Safety|August 9, 2002
Regulatory decisions in a globalised world: the domino effect of phenylpropanolamine withdrawal in Latin AmericaAlbert Figueras, Joan-Ramon LaportePageof 309